Fresenius Kabi iPSUM S.r.l

Fresenius Kabi iPSUM S.r.l


Company description

Part of the Fresenius Kabi  Group, Fresenius Kabi iPSUM is one of the leaders in cGMP sterile manufacturing of beta-lactam Active Pharmaceutical Ingredients (APIs). Based in Italy, Fresenius Kabi iPSUM supplies over 40 different products in the category of Penicillins and Cephalosporins to more than 70 countries.

The latest state of the art facilities are approved by all major health authorities including FDA, EDQM and AIFA.

Its offering includes also a range of oncology APIs and finished products manufactured in its own facilities in India.

The company's portfolio is complemented with several new APIs every year as Fresenius Kabi iPSUM is strongly committed to development and launch of first to market generic APIs .

 Sales Markets :
Western Europe
Eastern Europe
Middle East
North America
Central/South America


Quick facts

Sales markets Western Europe; Eastern Europe; Middle East; Asia; Australia; North America; Africa; Central/South America
Affiliated categories: Biotechnology and related specialities |Contract Manufacturing |Pharmaceutical Technology (general category) More

Recently at

5 nov 2019

CPhI Worldwide 2019

5-7 November 2019 Frankfurt, Germany We were at stand 60C31 See our Exhibitor Profile   See full Exhibitor List
Fresenius Kabi iPSUM S.r.l

Contact information




View all contact information